{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:32:52Z","timestamp":1791196372068,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.plefa.2010.07.001","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T12:53:05Z","timestamp":1280321585000},"page":"131-136","source":"Crossref","is-referenced-by-count":83,"title":["Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia"],"prefix":"10.1016","volume":"83","author":[{"given":"M.M.","family":"Sethom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bouaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Melki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jemaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Feki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Hechmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kaabachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2010.07.001_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-4159.1975.tb12235.x","article-title":"Effects of different dietary levels of essential fatty acids on the fatty acid composition of ethanolamine phosphoglycerides in myelin and synaptosoma plasma membranes","volume":"25","author":"Karlsson","year":"1975","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plefa.2010.07.001_bib2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(77)92228-0","article-title":"Schizophrenia as a prostaglandin deficiency disease","volume":"1","author":"Horrobin","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2010.07.001_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0920-9964(94)90045-0","article-title":"Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition","volume":"13","author":"Yao","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-9964(94)90084-1","article-title":"A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases","volume":"12","author":"Glen","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0952-3278(96)90148-9","article-title":"Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation","volume":"55","author":"Peet","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2010.07.001_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","article-title":"Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics","volume":"58","author":"Khan","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0006-3223(00)00986-0","article-title":"Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group","volume":"49","author":"Assies","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2010.07.001_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2003.08.010","article-title":"Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment","volume":"69","author":"Evans","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2010.07.001_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","article-title":"Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients","volume":"53","author":"Arvindakshan","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2010.07.001_bib10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","article-title":"Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline","volume":"30","author":"Reddy","year":"2004","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.plefa.2010.07.001_bib11","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.plefa.2010.07.001_bib12","series-title":"Techniques in Diagnostic Human Biochemical Genetics","author":"Moser","year":"1991"},{"key":"10.1016\/j.plefa.2010.07.001_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","article-title":"Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia","volume":"47","author":"Fenton","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2010.07.001_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<565::AID-JNR2>3.0.CO;2-H","article-title":"Essential fatty acids are mediators of brain biochemistry and cognitive functions","volume":"56","author":"Yehuda","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/342918a0","article-title":"Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells","volume":"342","author":"Barbour","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2010.07.001_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuint.2009.02.018","article-title":"Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid","volume":"54","author":"Grintal","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.plefa.2010.07.001_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.plefa.2006.07.009","article-title":"Modulation of phosphoinositide\u2013protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness","volume":"75","author":"McNamara","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2010.07.001_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-3223(02)01549-4","article-title":"Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder","volume":"53","author":"Hibbeln","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2010.07.001_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.plefa.2003.12.019","article-title":"Nutrition and schizophrenia: beyond omega-3 fatty acids","volume":"70","author":"Peet","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2010.07.001_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S0007114508992564","article-title":"Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1\u2013FADS2) gene cluster and the fatty acid composition of erythrocyte membranes","volume":"101","author":"Rzehak","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.plefa.2010.07.001_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archpsyc.1997.01830170113015","article-title":"Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2","volume":"54","author":"Ross","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2010.07.001_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.plefa.2003.08.009","article-title":"Environmental factors and membrane polyunsaturated fatty acids in schizophrenia","volume":"69","author":"Reddy","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2010.07.001_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11745-006-1392-2","article-title":"The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes","volume":"40","author":"Sands","year":"2005","journal-title":"Lipids"},{"key":"10.1016\/j.plefa.2010.07.001_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.psychres.2006.05.025","article-title":"Essential polyunsaturated fatty acids and social cognition in schizophrenia","volume":"157","author":"Sumiyoshi","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/pgmj.2008.073338","article-title":"Omega-3 fatty acids: a comprehensive review of their role in health and disease","volume":"85","author":"Yashodhara","year":"2009","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.plefa.2010.07.001_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.schres.2005.08.010","article-title":"A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls","volume":"80","author":"Goff","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.plefa.2006.07.013","article-title":"The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia","volume":"75","author":"Peet","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2010.07.001_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02637070","article-title":"Fatty acids and schizophrenia","volume":"31","author":"Laugharne","year":"1996","journal-title":"Lipids"},{"key":"10.1016\/j.plefa.2010.07.001_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145704004110","article-title":"Do we still believe in the dopamine hypothesis? New data bring new evidence","volume":"7","author":"Abi-Dargham","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.plefa.2010.07.001_bib31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ajcn\/75.4.662","article-title":"The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids","volume":"75","author":"Zimmer","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2010.07.001_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2006.11.027","article-title":"Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications","volume":"91","author":"McNamara","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.plefa.2003.08.018","article-title":"Omega-3 and omega-6 fatty acid concentrations in red blood cell membranes relate to schizotypal traits in healthy adults","volume":"69","author":"Richardson","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2010.07.001_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","article-title":"Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?","volume":"5","author":"Fern\u00f8","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.plefa.2010.07.001_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2008.09.027","article-title":"Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis","volume":"107","author":"McNamara","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.schres.2008.11.025","article-title":"Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia","volume":"108","author":"Polymeropoulos","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2010.07.001_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4088\/PCC.08r00612","article-title":"Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review","volume":"11","author":"Masand","year":"2009","journal-title":"Prim. Care Companion J. Clin. Psychiatry"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232781000116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232781000116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T20:06:42Z","timestamp":1559333202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232781000116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S095232781000116X"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2010.07.001","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}